Effects of <i>IGF2BP2, KCNQ1</i> and <i>GCKR</i> Polymorphisms on Clinical Outcome in Metastatic Gastric Cancer Treated with EOF RegimenXin Liu, Xiaodong Zhu, Guang He et al.|Pharmacogenomics|2015Cited by 36
Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapyRujiao Liu, Xiaodong Zhu, Xiaoying Zhao et al.|Tumor Biology|2015Cited by 13
Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapyWanjing Feng, Xiaodong Zhu, Xin Liu et al.|Oncology Letters|2018Cited by 3
Influence of hypoxia‑related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOFWenbo Tang, Zhiyu Chen, Weijian Guo et al.|Oncology Letters|2017Cited by 2